Auna (NYSE:AUNA) Announces Earnings Results

Auna (NYSE:AUNAGet Free Report) posted its quarterly earnings data on Tuesday. The company reported $0.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.11), FiscalAI reports. Auna had a net margin of 0.44% and a return on equity of 13.32%. The business had revenue of $362.85 million during the quarter, compared to the consensus estimate of $357.39 million.

Auna Price Performance

Auna stock opened at $5.42 on Thursday. Auna has a 52 week low of $4.09 and a 52 week high of $6.85. The company has a debt-to-equity ratio of 1.76, a quick ratio of 1.00 and a current ratio of 1.09. The stock has a fifty day moving average of $5.17 and a 200-day moving average of $5.11. The stock has a market capitalization of $401.13 million, a P/E ratio of 77.44 and a beta of 0.61.

Wall Street Analysts Forecast Growth

AUNA has been the subject of a number of analyst reports. JPMorgan Chase & Co. dropped their price target on shares of Auna from $6.00 to $5.00 and set a “neutral” rating for the company in a research report on Tuesday, May 26th. Wall Street Zen downgraded Auna from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 5th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Auna in a research note on Wednesday, June 24th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $6.97.

View Our Latest Analysis on AUNA

Insider Transactions at Auna

In other news, Director John Wilton sold 17,574 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $4.17, for a total value of $73,283.58. Following the sale, the director directly owned 49,974 shares in the company, valued at approximately $208,391.58. This trade represents a 26.02% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, President Leon Jesus Zamora acquired 30,000 shares of the stock in a transaction that occurred on Tuesday, May 26th. The shares were bought at an average price of $4.39 per share, with a total value of $131,700.00. Following the completion of the transaction, the president owned 45,914 shares in the company, valued at $201,562.46. This represents a 188.51% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders bought 77,640 shares of company stock valued at $331,539 in the last three months.

Hedge Funds Weigh In On Auna

Several large investors have recently bought and sold shares of the company. Marshall Wace LLP boosted its position in Auna by 391.0% during the 4th quarter. Marshall Wace LLP now owns 162,992 shares of the company’s stock worth $802,000 after buying an additional 129,799 shares during the period. Goldman Sachs Group Inc. increased its holdings in Auna by 43.1% in the fourth quarter. Goldman Sachs Group Inc. now owns 71,645 shares of the company’s stock valued at $352,000 after purchasing an additional 21,579 shares during the period. Jane Street Group LLC acquired a new stake in Auna in the fourth quarter valued at $201,000. Squarepoint Ops LLC bought a new position in Auna during the 4th quarter worth $196,000. Finally, Citadel Advisors LLC lifted its holdings in Auna by 28.9% during the 3rd quarter. Citadel Advisors LLC now owns 36,352 shares of the company’s stock worth $244,000 after buying an additional 8,147 shares during the period.

Auna Company Profile

(Get Free Report)

Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.

The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.

See Also

Earnings History for Auna (NYSE:AUNA)

Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.